Icikinase 1.5MIU Injection

Icikinase 1.5MIU Injection contains Streptokinase, is used to dissolve blood clots for conditions such as deep vein thrombosis, pulmonary embolism, and heart attack. It works by dissolving fibrin clots and reestablishing blood flow in blocked blood arteries.

Brand Name: Icikinase

Composition: Streptokinase

Mechanism of Action:

Streptokinase is a thrombolytic substance. It dissolves blood clots and improves blood flow by changing plasminogen into plasmin, an enzyme that breaks down fibrin clots.

Uses:

·       Heart attack

·       Pulmonary embolism

·       Deep vein thrombosis (DVT)

·       Arterial thrombosis

Dosage and Administration:

Given intravenously in a hospital under close medical monitoring. The patient's condition and the indication determine the dosage and duration.

Uses:

·       Fever

·       Hypotension

·       Nausea

·       Vomiting

·       Injection site reaction

·       Bleeding

·       Allergic reactions

Safety Advise:

Kidney  

Monitor kidney function regularly, as Icikinase can cause nephrotoxicity. Kindly speak with your healthcare provider.

Liver  

Monitor liver function regularly, as Icikinase can cause liver impairement. Kindly speak with your healthcare provider.

Pregnancy  

Icikinase should be used during pregnancy only if clearly needed, Kindly speak with your healthcare provider.

Breast Feeding  

Using Icikinase while nursing is most likely dangerous. Kindly speak with your healthcare provider.

Alcohol  

Icikinase should not be taken with alcohol. Kindly speak with your healthcare provider.

Storage:

Protect from light and store below 25°C.

Reference:

1.     https://www.mayoclinic.org/drugs-supplements/streptokinase-intravenous-route-intracoronary-route/description/drg-20070834

2.     Klöcking HP. Pharmacology of streptokinase. InFibrinolytics and Antifibrinolytics 1978 Sep 1 (pp. 151-177). Berlin, Heidelberg: Springer Berlin Heidelberg.

3.     Tillett WS, Johnson AJ, McCarty WR. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. The Journal of Clinical Investigation. 1955 Feb 1;34(2):169-85.

Disclaimer:

The main goal of Apothecare is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details:

Name: Abbott

Address: 16th Floor, Godrej BKC, Plot – C, “G” Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, India

Country of origin: India